Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Lozada-Delgado EL, Grafals-Ruiz N, Vivas-Mejía PE.

Life Sci. 2017 Nov 1;188:26-36. doi: 10.1016/j.lfs.2017.08.027. Epub 2017 Aug 31. Review.

PMID:
28864225
2.

The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.

Beyer S, Fleming J, Meng W, Singh R, Haque SJ, Chakravarti A.

Cancers (Basel). 2017 Jul 10;9(7). pii: E85. doi: 10.3390/cancers9070085. Review.

3.

MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.

Jiang K, Zhi T, Xu W, Xu X, Wu W, Yu T, Nie E, Zhou X, Bao Z, Jin X, Zhang J, Wang Y, Liu N.

Am J Cancer Res. 2017 Apr 1;7(4):784-800. eCollection 2017.

4.

Autophagy-Regulating microRNAs and Cancer.

Gozuacik D, Akkoc Y, Ozturk DG, Kocak M.

Front Oncol. 2017 Apr 18;7:65. doi: 10.3389/fonc.2017.00065. eCollection 2017. Review.

5.

Serum microRNA profiling in patients with glioblastoma: a survival analysis.

Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB.

Mol Cancer. 2017 Mar 11;16(1):59. doi: 10.1186/s12943-017-0628-5.

6.

Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.

El Fatimy R, Subramanian S, Uhlmann EJ, Krichevsky AM.

Mol Ther. 2017 Feb 1;25(2):368-378. doi: 10.1016/j.ymthe.2016.11.004.

PMID:
28153089
7.

Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions.

Munthe S, Halle B, Boldt HB, Christiansen H, Schmidt S, Kaimal V, Xu J, Zabludoff S, Mollenhauer J, Poulsen FR, Kristensen BW.

J Neurooncol. 2017 Mar;132(1):45-54. doi: 10.1007/s11060-016-2356-x. Epub 2017 Jan 13.

8.

Evolutionary patterns of metazoan microRNAs reveal targeting principles in the let-7 and miR-10 families.

Wolter JM, Le HH, Linse A, Godlove VA, Nguyen TD, Kotagama K, Lynch A, Rawls A, Mangone M.

Genome Res. 2017 Jan;27(1):53-63. doi: 10.1101/gr.209361.116. Epub 2016 Dec 7.

9.

miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).

Zhu Q, Gong L, Wang J, Tu Q, Yao L, Zhang JR, Han XJ, Zhu SJ, Wang SM, Li YH, Zhang W.

BMC Cancer. 2016 Oct 18;16(1):806.

10.

Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.

Kim J, Siverly AN, Chen D, Wang M, Yuan Y, Wang Y, Lee H, Zhang J, Muller WJ, Liang H, Gan B, Yang X, Sun Y, You MJ, Ma L.

Cancer Res. 2016 Nov 1;76(21):6424-6435. Epub 2016 Aug 28.

PMID:
27569213
11.

MiR-10b decreases sensitivity of glioblastoma cells to radiation by targeting AKT.

Zhen L, Li J, Zhang M, Yang K.

J Biol Res (Thessalon). 2016 Jun 24;23:14. doi: 10.1186/s40709-016-0051-x. eCollection 2016 Dec.

12.

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, Verma M, Kumar D.

Cancer Med. 2016 Aug;5(8):1917-46. doi: 10.1002/cam4.775. Epub 2016 Jun 10. Review.

13.

MicroRNA-544 inhibits glioma proliferation, invasion and migration but induces cell apoptosis by targeting PARK7.

Jin S, Dai Y, Li C, Fang X, Han H, Wang D.

Am J Transl Res. 2016 Apr 15;8(4):1826-37. eCollection 2016.

14.

Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.

Bronisz A, Godlewski J, Chiocca EA.

Cell Mol Neurobiol. 2016 Apr;36(3):361-76. doi: 10.1007/s10571-015-0293-4. Epub 2016 Mar 17. Review.

15.

MicroRNA and extracellular vesicles in glioblastoma: small but powerful.

Rooj AK, Mineo M, Godlewski J.

Brain Tumor Pathol. 2016 Apr;33(2):77-88. doi: 10.1007/s10014-016-0259-3. Epub 2016 Mar 11. Review.

16.

Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.

Zhao Y, Alexandrov PN, Lukiw WJ.

Front Neurosci. 2016 Feb 25;10:59. doi: 10.3389/fnins.2016.00059. eCollection 2016.

17.

Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer.

Li Y, Li Y, Liu J, Fan Y, Li X, Dong M, Liu H, Chen J.

Cancer Biol Ther. 2016;17(3):272-9. doi: 10.1080/15384047.2016.1139242. Epub 2016 Jan 30.

18.

Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.

Teplyuk NM, Uhlmann EJ, Gabriely G, Volfovsky N, Wang Y, Teng J, Karmali P, Marcusson E, Peter M, Mohan A, Kraytsberg Y, Cialic R, Chiocca EA, Godlewski J, Tannous B, Krichevsky AM.

EMBO Mol Med. 2016 Mar 1;8(3):268-87. doi: 10.15252/emmm.201505495.

19.

MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.

Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Guo X, Zhang P, Gao X, Liu Q, Li G.

Oncotarget. 2016 Jan 26;7(4):4785-805. doi: 10.18632/oncotarget.6735.

20.

miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.

Kouri FM, Ritner C, Stegh AH.

Cell Cycle. 2015;14(24):3794-800. doi: 10.1080/15384101.2015.1093711.

Supplemental Content

Support Center